113 related articles for article (PubMed ID: 23089923)
1. Maternal SNPs in the p53 pathway: risk factors for trisomy 21?
Boquett JA; Brandalize AP; Fraga LR; Schuler-Faccini L
Dis Markers; 2013; 34(1):41-9. PubMed ID: 23089923
[TBL] [Abstract][Full Text] [Related]
2. Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations.
Fang S; Krahe R; Lozano G; Han Y; Chen W; Post SM; Zhang B; Wilson CD; Bachinski LL; Strong LC; Amos CI
PLoS One; 2010 May; 5(5):e10813. PubMed ID: 20520810
[TBL] [Abstract][Full Text] [Related]
3. Single-nucleotide polymorphisms in p53 pathway and aggressiveness of prostate cancer in a Caucasian population.
Sun T; Lee GS; Oh WK; Pomerantz M; Yang M; Xie W; Freedman ML; Kantoff PW
Clin Cancer Res; 2010 Nov; 16(21):5244-51. PubMed ID: 20855462
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis.
Gansmo LB; Lie BA; Mæhlen MT; Vatten L; Romundstad P; Hveem K; Lønning PE; Knappskog S
Gene; 2021 Aug; 793():145747. PubMed ID: 34077778
[TBL] [Abstract][Full Text] [Related]
5. Genetic association of single nucleotide polymorphisms in P53 pathway with gastric cancer risk in a Chinese Han population.
Wu GC; Zhang ZT
Med Oncol; 2015 Jan; 32(1):401. PubMed ID: 25479941
[TBL] [Abstract][Full Text] [Related]
6. Interaction between TP63 and MDM2 genes and the risk of recurrent pregnancy loss.
Fraga LR; Boquett JA; Dutra CG; Vianna FS; Heck C; Gonçalves RO; Paskulin DD; Costa OL; Ashton-Prolla P; Sanseverino MT; Schuler-Faccini L
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():7-10. PubMed ID: 25218545
[TBL] [Abstract][Full Text] [Related]
7. A polymorphism (rs1042522) in TP53 gene is a risk factor for Down Syndrome in Sicilian mothers.
Salemi M; Barone C; Salluzzo MG; Giambirtone M; Scillato F; Galati Rando R; Romano C; Morale MC; Ridolfo F; Romano C
J Matern Fetal Neonatal Med; 2017 Nov; 30(22):2752-2754. PubMed ID: 27852141
[TBL] [Abstract][Full Text] [Related]
8. Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients.
Schmidt MK; Tommiska J; Broeks A; van Leeuwen FE; Van't Veer LJ; Pharoah PD; Easton DF; Shah M; Humphreys M; Dörk T; Reincke SA; Fagerholm R; Blomqvist C; Nevanlinna H
Breast Cancer Res; 2009; 11(6):R89. PubMed ID: 20021639
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancer.
Misra C; Majumder M; Bajaj S; Ghosh S; Roy B; Roychoudhury S
Mol Carcinog; 2009 Sep; 48(9):790-800. PubMed ID: 19204927
[TBL] [Abstract][Full Text] [Related]
10. Association of rheumatoid arthritis with Mdm2 SNP309 and genetic evidence for an allele-specific interaction between MDM2 and p53 P72R variants: a case control study.
Assmann G; Voswinkel J; Mueller M; Bittenbring J; Koenig J; Menzel A; Pfreundschuh M; Roemer K; Melchers I
Clin Exp Rheumatol; 2009; 27(4):615-9. PubMed ID: 19772793
[TBL] [Abstract][Full Text] [Related]
11. p53 signaling pathway polymorphisms associated to recurrent pregnancy loss.
Fraga LR; Dutra CG; Boquett JA; Vianna FS; Gonçalves RO; Paskulin DD; Costa OL; Ashton-Prolla P; Sanseverino MT; Schuler-Faccini L
Mol Biol Rep; 2014 Mar; 41(3):1871-7. PubMed ID: 24435975
[TBL] [Abstract][Full Text] [Related]
12. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.
Qiu M; Liu Y; Yu X; Qin L; Bei C; Zeng X; Qiu X; Tang B; He S; Yu H
Tumour Biol; 2016 Mar; 37(3):3863-70. PubMed ID: 26476535
[TBL] [Abstract][Full Text] [Related]
13. p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers.
Macedo GS; Vieira IA; Vianna FSL; Alemar B; Giacomazzi J; Brandalize APC; Caleffi M; Volc SM; de Campos Reis Galvão H; Palmero EI; Achatz MI; Ashton-Prolla P
Fam Cancer; 2018 Apr; 17(2):269-274. PubMed ID: 28756477
[TBL] [Abstract][Full Text] [Related]
14. Association of p73 and MDM2 polymorphisms with the risk of epithelial ovarian cancer in Chinese women.
Kang S; Wang DJ; Li WS; Wang N; Zhou RM; Sun DL; Duan YN; Li SZ; Li XF; Li Y
Int J Gynecol Cancer; 2009 May; 19(4):572-7. PubMed ID: 19509552
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D
Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants in p53-related genes confer susceptibility to second primary malignancy in patients with index squamous cell carcinoma of head and neck.
Jin L; Sturgis EM; Zhang Y; Huang Z; Wei P; Guo W; Wang Z; Wei Q; Song X; Li G
Carcinogenesis; 2013 Jul; 34(7):1551-7. PubMed ID: 23508638
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of p73 and MDM2 polymorphisms on the risk of lung cancer.
Jun HJ; Park SH; Lee WK; Choi JE; Jang JS; Kim EJ; Cha SI; Kim DS; Kam S; Kim CH; Kang YM; Jung TH; Park JY
Mol Carcinog; 2007 Feb; 46(2):100-5. PubMed ID: 17013834
[TBL] [Abstract][Full Text] [Related]
18. Combined p53-related genetic variants together with HPV infection increase oral cancer risk.
Wang Z; Sturgis EM; Zhang Y; Huang Z; Zhou Q; Wei Q; Li G
Int J Cancer; 2012 Aug; 131(3):E251-8. PubMed ID: 22052649
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of TP53 Pro72Arg and MDM2 SNP285-SNP309 polymorphisms in an Italian cohort of LFS suggestive patients lacking identifiable TP53 germline mutations.
Ponti F; Corsini S; Gnoli M; Pedrini E; Mordenti M; Sangiorgi L
Fam Cancer; 2016 Oct; 15(4):635-43. PubMed ID: 26956143
[TBL] [Abstract][Full Text] [Related]
20. Combined effect of genetic polymorphisms in P53, P73, and MDM2 on non-small cell lung cancer survival.
Liu L; Wu C; Wang Y; Zhong R; Duan S; Wei S; Lin S; Zhang X; Tan W; Yu D; Nie S; Miao X; Lin D
J Thorac Oncol; 2011 Nov; 6(11):1793-800. PubMed ID: 21841506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]